Teladoc Health (TDOC) reported a Q4 loss late Wednesday of $0.28 per diluted share, wider than a loss of $0.17 a year earlier.

Analysts polled by FactSet expected a loss of $0.26.

Revenue for the quarter ended Dec. 31 was $640.5 million, compared with $660.5 million a year earlier.

Analysts surveyed by FactSet expected $639.5 million.

The company said it expects a Q1 net loss of $0.40 to $0.15 per share on revenue of $608 million to $629 million. Analysts surveyed by FactSet expect a loss of $0.33 per share on revenue of $626.7 million.

For 2025, the company expects a loss between $1.10 to $0.50 per share on revenue of $2.47 billion to $2.58 billion. Analysts surveyed by FactSet expect a loss of $0.94 per share on revenue of $2.53 billion.

Shares of the company fell 15.5% in premarket activity Thursday.